AMED's planned merger with UnitedHealth remains on the rocks with regulatory overhang still an issue. The deal is also asymmetrically weighted in UNH's favor, with the latter up for no penalty if it fails. Not so for AMED. Aside from this, there are internal factors dragging on AMED's business performance.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
| - Industry | - Sector | Richard M. Ashworth CEO | NASDAQ (NGS) Exchange | 023436108 CUSIP |
| US Country | 19,000 Employees | - Last Dividend | 5 Dec 2006 Last Split | 17 Aug 1994 IPO Date |
Amedisys, Inc., a healthcare service provider based in the United States, operates nationally with a focus on delivering personalized home health, hospice, and high acuity care. Established in 1982 and headquartered in Baton Rouge, Louisiana, the company has evolved to meet the needs of patients across three primary segments. Aimed at enhancing the healthcare delivery system, Amedisys, Inc. utilizes a comprehensive approach that revolves around delivering specialized care directly to patients' homes, thereby personifying its mission to maintain and improve the quality of life for those under its care.
This segment provides a wide variety of services including post-surgery recovery, chronic disability management, and terminal illness care, directly in the comfort of the patient's home. To prevent unnecessary hospital readmissions, Amedisys utilizes skilled nurses, rehabilitation therapists specializing in physical, speech, and occupational therapy, and social workers. This multidisciplinary approach ensures comprehensive care tailored to each patient's unique needs.
Aimed at offering comfort and support to individuals facing terminal illnesses such as cancer, heart disease, pulmonary disease, or Alzheimer's, this segment focuses on palliative care. The hospice care by Amedisys is designed to alleviate pain and make the patient's remaining time as meaningful and comfortable as possible, involving family and loved ones in the care process.
This segment offers care similar to that which is provided in an inpatient hospital or skilled nursing facility, but in the patient's home. It includes essential elements of both settings and is enhanced with palliative care services. The high acuity care model is an innovative approach to treating patients with complex medical needs, enabling them to receive high-level care in their familiar surroundings.